---
title: "China Innovation Flags Governance and Meeting Irregularities at Elife Holdings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273853768.md"
description: "China Innovation Investment Limited (HK:1217) has raised concerns over corporate governance at Elife Holdings, claiming that three executive directors' terms should have expired in September 2025, making their actions invalid. The investor alleges that notices for Elife's January 2026 meetings did not comply with statutory notice periods and Hong Kong listing rules. They have requested the meetings be adjourned or canceled and may seek court relief. The current analyst rating for HK:1217 is a Buy with a price target of HK$0.01."
datetime: "2026-01-27T14:08:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273853768.md)
  - [en](https://longbridge.com/en/news/273853768.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273853768.md)
---

# China Innovation Flags Governance and Meeting Irregularities at Elife Holdings

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

China Innovation Investment Limited ( (HK:1217) ) has provided an announcement.

China Innovation Investment Limited, as a substantial shareholder of Elife Holdings Limited, has publicly raised serious concerns over corporate governance practices at Elife, alleging that three executive directors’ terms should have automatically expired in September 2025 under Elife’s articles of association, rendering their subsequent actions on behalf of the company invalid. The investor further contends that notices convening Elife’s January 2026 annual and extraordinary general meetings failed to comply with statutory notice periods and Hong Kong listing rules on closure of the register of members, and has formally requested that Elife adjourn or cancel the scheduled meetings while reserving its right to seek court relief to protect the interests of all shareholders.

The most recent analyst rating on (HK:1217) stock is a Buy with a HK$0.01 price target. To see the full list of analyst forecasts on China Innovation Investment Limited stock, see the HK:1217 Stock Forecast page.

**More about China Innovation Investment Limited**

China Innovation Investment Limited, incorporated in the Cayman Islands and listed in Hong Kong, is an investment company that holds substantial stakes in other listed entities, including Elife Holdings Limited. Through its shareholdings, it is an active financial investor focusing on governance and compliance matters at its portfolio companies to safeguard shareholder interests.

**Average Trading Volume:** 20,047,575

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$166.4M

Learn more about 1217 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [00223.HK](https://longbridge.com/en/quote/00223.HK.md)
- [01217.HK](https://longbridge.com/en/quote/01217.HK.md)

## Related News & Research

- [Kish Bancorp GAAP EPS of $1.76, revenue of $19.60M](https://longbridge.com/en/news/282744581.md)
- [Tidal Wave Auto Spa Announces Grand Opening in North Augusta, South Carolina](https://longbridge.com/en/news/282901319.md)
- [Anthropic's mysterious Mythos AI threatens to upend the infosec world](https://longbridge.com/en/news/282459612.md)
- [Segway launches compact cargo e-bike with some really nice specs](https://longbridge.com/en/news/282696147.md)
- [Leapmotor to launch Lafa 5 Ultra at Beijing Auto Show on Apr 24](https://longbridge.com/en/news/282529374.md)